ADMA Biologics Inc Stock News

ADMA Biologics recently publicized their first commercial sale of their IVIG product, ASCENIV. Now, the company has three commercial products and multiple sources of revenue.

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 22, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufa

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 21, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufa

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufa

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 07, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and s

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and

ADMA Biologics has re-launched their IVIG product, BIVIGAM, during a nationwide IG shortage. With ASCENIV's launch approaching, I expect ADMA to capitalize on the current market conditions.

RAMSEY, N.J. and BOCA RATON, Fla., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and s

For a company that just racked up two significant regulatory wins, ADMA Biologics Inc.

These seven cheap stocks under $10 all have massive upside potential according to Wall Street's top analysts. The post 7 High-Quality Cheap Stocks to Buy With $10 appeared first on InvestorPlace.

After years of struggle, ADMA Biologics appears at last to be poised for bigger things.

Shares have lost over a third of their value during the past three years.

Since April, ADMA has won approval for two IVIG products, Asceniv and Bivigam, as well as approval to manufacture them in its vertically integrated facility.

Here's a roundup of top developments in the biotech space over the last 24 hours.

Microcap specialty pharma company ADMA Biologics Inc. advanced in the last two trading days in anticipation of a binary event, and with the event materializing in favor of the company, the stock has t